Correlation Between Embracer Group and Chordate Medical

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Embracer Group and Chordate Medical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Embracer Group and Chordate Medical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Embracer Group AB and Chordate Medical Holding, you can compare the effects of market volatilities on Embracer Group and Chordate Medical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Embracer Group with a short position of Chordate Medical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Embracer Group and Chordate Medical.

Diversification Opportunities for Embracer Group and Chordate Medical

-0.34
  Correlation Coefficient

Very good diversification

The 3 months correlation between Embracer and Chordate is -0.34. Overlapping area represents the amount of risk that can be diversified away by holding Embracer Group AB and Chordate Medical Holding in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Chordate Medical Holding and Embracer Group is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Embracer Group AB are associated (or correlated) with Chordate Medical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Chordate Medical Holding has no effect on the direction of Embracer Group i.e., Embracer Group and Chordate Medical go up and down completely randomly.

Pair Corralation between Embracer Group and Chordate Medical

Assuming the 90 days trading horizon Embracer Group AB is expected to generate 0.49 times more return on investment than Chordate Medical. However, Embracer Group AB is 2.05 times less risky than Chordate Medical. It trades about 0.04 of its potential returns per unit of risk. Chordate Medical Holding is currently generating about -0.05 per unit of risk. If you would invest  2,720  in Embracer Group AB on September 24, 2024 and sell it today you would earn a total of  320.00  from holding Embracer Group AB or generate 11.76% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Embracer Group AB  vs.  Chordate Medical Holding

 Performance 
       Timeline  
Embracer Group AB 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Embracer Group AB are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Despite somewhat uncertain basic indicators, Embracer Group sustained solid returns over the last few months and may actually be approaching a breakup point.
Chordate Medical Holding 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Chordate Medical Holding has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's technical indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Embracer Group and Chordate Medical Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Embracer Group and Chordate Medical

The main advantage of trading using opposite Embracer Group and Chordate Medical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Embracer Group position performs unexpectedly, Chordate Medical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Chordate Medical will offset losses from the drop in Chordate Medical's long position.
The idea behind Embracer Group AB and Chordate Medical Holding pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.

Other Complementary Tools

Equity Valuation
Check real value of public entities based on technical and fundamental data
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance